Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Hutchison Baiyunshan To Hand Out Medicine Coupons

This article was originally published in PharmAsia News

Executive Summary

Amid the financial crisis, billionaire Li Ka-shing's Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine will issue 6 million medicine coupons worth RMB 30 million nationwide to alleviate the burden of drug expenses for people in China. Consumers can get coupons with a face value of RMB 10-20 to purchase designated Hutchison Baiyunshan-made drugs. This is the first coupon distribution program targeting branded-drug consumption in the country. The exercise will allow the company to promote its products, capture funds, as well as benefit users. Analysts note that it has been Li's style to give profits back to consumers during past economic downturns. (Click here for more - Chinese Language)

You may also be interested in...



COVID-19 Magnifies US Need To Make Supplements Eligible For Pre-Tax Savings – NPA

NPA asks Congress to include supplements in legislation defining "medical expenses” covered by pre-tax health savings accounts. The trade group says industry would prefer supplements were included with OTC drugs in provision in recently passed COVID-19 relief legislation that changed pre-tax account rules.

COVID-19: ResMed Ramps Up CPAP, BPAP Manufacturing To Address Ventilator Shortage

ResMed plans to double or even triple production of intensive ventilators and sleep apnea machines this year amid rising demand by hospitals to use CPAP and BPAP machines to treat COVID-19 patients during the ventilator shortage. 

Industry, Agencies Are Making COVID-19 Partnerships Easy

Organizations like BARDA, CEPI and others are looking to partner with industry to rapidly test, manufacture, package and deploy vaccines and therapeutics, identifying areas they want to work together during BIO’s recent summit.

UsernamePublicRestriction

Register

SC071046

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel